- Accession Number:
- Form Type:
- Zero Holdings:
- Publication Time:
- 2011-04-20 19:39:57
- Reporting Period:
- Filing Date:
- Accepted Time:
- 2011-04-20 19:39:57
- SEC Url:
- Form 4 Filing
|Cik||Name||Symbol||Sector (SIC)||IRS No|
|897448||Amarin Corp Plc||AMRN||Pharmaceutical Preparations (2834)||000000000|
|Cik||Name||Reported Address||Insider Title||Director||Officer||Large Shareholder||Other|
|1508485||Paresh Soni||C/o Amarin Pharma, Inc. |
Mystic Packer Bldg, 12 Roosevelt Avenue
Mystic CT 06355
|Svp And Head Of Development||No||Yes||No||No|
|Sec. Name||Acquisiton - Disposition||Date||Amount||Price||Remaning Holdings||Equity Swap Involved||Form Type||Code||Nature of Ownership||Explanation|
|Equity Swap Involved||Form Type||Code||Nature of Ownership||Explanation|
|Sec. Name||Sec. Type||Acquisiton - Disposition||Date||Amount||Price||Amount - 2||Price - 2|
|Ordinary Shares||Stock Option (right to buy)||Disposition||2011-04-19||80,000||$0.00||80,000||$1.35|
|Remaning Holdings||Exercise Date||Expiration Date||Equity Swap Involved||Transaction Form Type||Transaction Code||Nature of Ownership|
- The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.
- On December 21, 2009, the reporting person was granted an option under the Amarin Corporation plc 2002 Stock Option Plan. The stock option initially vested in four equal installments on each anniversary of such grant date. In December 2010, the Issuer's Board of Directors approved the acceleration of the vesting of this award by six months such that the option vests in four equal installments and will be fully vested on June 21, 2013.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $14.9025 to $15.26, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
- The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.